{"disease":{"id":"relapsed-b-cell-acute-lymphoblastic-leukemia-after-cd19-car-t-aci","name":"relapsed b cell acute lymphoblastic leukemia after cd19 car t aci"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03754764","title":"A Feasibility and Safety Study of CD38 CAR-T Cell Immunotherapy for Relapsed B-cell Acute Lymphoblastic Leukemia After CD19 CAR-T Adoptive Cellular Immunotherapy","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}